
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group reported total revenue of $1,649 million, reflecting an 8.1% year-over-year increase, attributed to strong demand in its Market Data segment, which experienced a growth of 14.5% in the quarter. The company has demonstrated robust free cash flow generation, enabling it to increase quarterly dividend payments consistently for over 14 years, highlighting its financial stability and commitment to returning capital to shareholders. Additionally, CME has successfully increased its average daily volume (ADV) at a compound annual growth rate of over 7% from FY16 through FY24, indicating effective product innovation and heightened customer demand in a favorable market environment.
Bears say
CME Group's financial outlook is negatively impacted by anticipated declines in interest rate futures trading volume due to a projected rate-cutting cycle, with expectations for total revenue growth of approximately 5.4% year-over-year to around $6,872 million, falling short of the consensus estimate of 6% growth to about $6,911 million. Furthermore, heightened competitive threats from entities like FMX contribute to pricing pressures, limiting near-term margin upside for the company. The management also highlighted challenges in separating Google-related expenses from baseline technology spending, indicating potential future cost management complexities.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares